PMC:7402624 / 16575-16800 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T114","span":{"begin":28,"end":32},"obj":"Body_part"},{"id":"T115","span":{"begin":175,"end":179},"obj":"Body_part"},{"id":"T116","span":{"begin":198,"end":203},"obj":"Body_part"}],"attributes":[{"id":"A114","pred":"fma_id","subj":"T114","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A115","pred":"fma_id","subj":"T115","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A116","pred":"fma_id","subj":"T116","obj":"http://purl.org/sig/ont/fma/fma9670"}],"text":"Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a substantial fraction of patients had little evidence of CD8 T cell activation in the blood compared to controls."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T8","span":{"begin":198,"end":203},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a substantial fraction of patients had little evidence of CD8 T cell activation in the blood compared to controls."}

{"project":"LitCovid-PubTator","denotations":[{"id":"513","span":{"begin":22,"end":25},"obj":"Gene"},{"id":"514","span":{"begin":169,"end":172},"obj":"Gene"},{"id":"521","span":{"begin":101,"end":109},"obj":"Species"},{"id":"522","span":{"begin":137,"end":145},"obj":"Species"},{"id":"533","span":{"begin":92,"end":100},"obj":"Disease"}],"attributes":[{"id":"A513","pred":"tao:has_database_id","subj":"513","obj":"Gene:925"},{"id":"A514","pred":"tao:has_database_id","subj":"514","obj":"Gene:925"},{"id":"A521","pred":"tao:has_database_id","subj":"521","obj":"Tax:9606"},{"id":"A522","pred":"tao:has_database_id","subj":"522","obj":"Tax:9606"},{"id":"A533","pred":"tao:has_database_id","subj":"533","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a substantial fraction of patients had little evidence of CD8 T cell activation in the blood compared to controls."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T126","span":{"begin":92,"end":100},"obj":"Disease"}],"attributes":[{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a substantial fraction of patients had little evidence of CD8 T cell activation in the blood compared to controls."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T263","span":{"begin":22,"end":25},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T264","span":{"begin":26,"end":32},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T265","span":{"begin":33,"end":43},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T266","span":{"begin":48,"end":49},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T267","span":{"begin":111,"end":112},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T268","span":{"begin":169,"end":172},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T269","span":{"begin":173,"end":179},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T270","span":{"begin":180,"end":190},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T271","span":{"begin":198,"end":203},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T272","span":{"begin":198,"end":203},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"}],"text":"Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a substantial fraction of patients had little evidence of CD8 T cell activation in the blood compared to controls."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T41","span":{"begin":26,"end":43},"obj":"http://purl.obolibrary.org/obo/GO_0042110"},{"id":"T42","span":{"begin":28,"end":43},"obj":"http://purl.obolibrary.org/obo/GO_0001775"},{"id":"T43","span":{"begin":173,"end":190},"obj":"http://purl.obolibrary.org/obo/GO_0042110"},{"id":"T44","span":{"begin":175,"end":190},"obj":"http://purl.obolibrary.org/obo/GO_0001775"}],"text":"Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a substantial fraction of patients had little evidence of CD8 T cell activation in the blood compared to controls."}

{"project":"LitCovid-sentences","denotations":[{"id":"T106","span":{"begin":0,"end":225},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a substantial fraction of patients had little evidence of CD8 T cell activation in the blood compared to controls."}